Harvard Infectious Diseases in Adults 2021

Overview

Harvard Infectious Diseases in Adults 2021 presents state-of-the-art approaches to the prevention, diagnosis, and treatment of infectious diseases in adult patients. This program includes an expanded range of interactive, case-based, and problem-solving education designed to strengthen clinical expertise in infectious diseases management.

On-demand internal medicine education — accessible anytime, anywhere.

Content

This course offers a comprehensive update on current strategies and best practices in infectious diseases, emphasizing clinically relevant applications and decision-making processes.

• Expanded Case-Based and Problem-Solving Education: Engaging formats with opportunities to interact with national experts through Q&A sessions following lectures and workshops.
• Treating Highly Resistant Infections: Coverage of MRSA and VISA (vancomycin-intermediate Staph aureus), ESBL-producing gram-negative rods, carbapenemase-producing organisms including NDM-1, vancomycin-resistant enterococci (VRE), Aspergillus and non-aspergillus mold infections, Candida auris, and nontuberculous mycobacteria (NTM).
• Updates on Common Infectious Diseases: Prevention, diagnosis, and treatment updates for infections in immunocompromised populations, persons with substance use disorders, travelers and foreign-born persons, systemic fungal infections, orthopedic infections (native and device-related), central nervous system infections, ENT and eye infections, bronchiectasis and pneumonia, HIV and its complications, PEP and PrEP for HIV prevention, sexually transmitted infections, hepatitis B and C, tick- and mosquito-borne infections, vaccines and vaccine-preventable infections, and Clostridioides difficile infection.
• Challenging, Rare, and Emerging Infectious Diseases: Updates on COVID-19, EEE, Zika, Ebola, MERS, vaccine-preventable disease re-emergence, pulmonary and extrapulmonary non-tuberculous mycobacteria including Mycobacterium abscessus, and globally important infectious diseases.
• Clinical Decision-Making: Expert guidance on selecting antimicrobials and treatment durations, rapid detection and empiric treatment of life-threatening infections, inpatient vs outpatient management, and optimizing empiric antimicrobial therapy.
• Multidisciplinary Approaches: Coverage of antimicrobial stewardship, infection control including biothreats, early inpatient infectious disease consultations, and management strategies for infections in persons who inject drugs (PWID).
• Optimized for Remote Education: Originally live streamed sessions recorded for online viewing availability for 30 days post-course.

Speakers

This program features presentations and workshops led by nationally recognized infectious disease specialists and master clinicians with extensive experience in adult infectious diseases, providing expert perspectives on clinical practice and decision-making.

Target Audience

This course is intended for physicians, infectious disease specialists, internists, hospitalists, and other healthcare professionals involved in the diagnosis, treatment, and management of infectious diseases in adult patients seeking to enhance their clinical knowledge and application skills.

Why This Topic Matters

Harvard Infectious Diseases in Adults 2021 addresses critical updates and evolving challenges in the field of adult infectious diseases, reflecting advances relevant to the internal medicine specialty. The program’s comprehensive approach supports clinicians in maintaining current knowledge of prevention, diagnosis, and treatment strategies.

Accessed through MedHub Central, this program provides a valuable resource for strengthening expertise in infectious diseases, helping healthcare professionals navigate complex clinical scenarios with confidence and evidence-based decision-making.